High Blood Pressure and Cardiovascular Prevention This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Intergenerational Hypertension Prevention Education for Children and Family Members: A Longitudinal Assessment
ConclusionsEven one-off short RS-based interventions with children can be sufficient to increase hypertension awareness for AFMs. An experiential component in similar family-targeted RS programs can capitalize on improvements in self-efficacy and intention to effect sustained behaviour change in hypertension preventive behaviours. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - February 8, 2023 Category: Cardiology Source Type: research

Risk Factors Control After an Acute Coronary Syndrome and Association with Major Adverse Cardiovascular Events: A Single Center Experience in Latin-America
ConclusionAchieving established goals for modifiable RFs can lower the incidence of MACE during long-term follow-up. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - February 3, 2023 Category: Cardiology Source Type: research

Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations
AbstractBlood pressure control remains an unmet clinical need. Only about half of patients achieve their blood pressure (BP) targets and of these, the majority require combination and double or triple therapies. International guidelines recommend the association of drugs with complementary mechanisms of action and, in particular, the combination of renin-angiotensin system (RAS) inhibitors, calcium channel blockers (CCBs), and diuretics. Among the various angiotensin receptor blockers, olmesartan (OM) is available as a monotherapy and in dual and triple single-pill combinations (SPCs) with amlodipine (AML) and/or hydrochlo...
Source: High Blood Pressure and Cardiovascular Prevention - January 25, 2023 Category: Cardiology Source Type: research

Acknowledgment to Referees
(Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - January 23, 2023 Category: Cardiology Source Type: research

Altered baroreflex sensitivity at rest and during Valsalva maneuver in healthy male offspring of hypertensive patients
ConclusionThe reduced BRS and sympathovagal imbalance in male offspring of hypertensive parents reveal the early risk of developing hypertension in the future. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - January 17, 2023 Category: Cardiology Source Type: research

An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives
AbstractThe glycoprotein (GP) IIb/IIIa receptor is found integrin present in platelet aggregations. GP IIb/IIIa antagonists interfere with platelet cross-linking and platelet-derived thrombus formation through the competition with fibrinogen and von Willebrand factor. Currently, three parenteral GP IIb/IIIa competitors (tirofiban, eptifibatide, and abciximab) are approved for clinical use in patients affected by percutaneous coronary interventions (PCI) in the location of acute coronary syndrome (ACS). GP IIb/IIIa antagonists have their mechanism of action in platelet aggregation prevention, distal thromboembolism, and thr...
Source: High Blood Pressure and Cardiovascular Prevention - January 13, 2023 Category: Cardiology Source Type: research

Metabolic Dysfunction-Associated Fatty Liver Disease in Newly Diagnosed, Treatment-Naive Hypertensive Patients and Its Association with Cardiorenal Risk Markers
ConclusionMAFLD represents a common comorbidity in hypertensive patients and is associated with markers of cardiorenal risk. Uric acid may be indicative of MAFLD in particular. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - January 10, 2023 Category: Cardiology Source Type: research

Practical Guidelines for Patients with Hypertension and Periodontitis
AbstractArterial hypertension (AH) and periodontitis are among the most common non-communicable chronic diseases worldwide. Besides sharing common risk factors, an increasing body of evidence supports an independent association between the two conditions, with low-grade systemic inflammation acting as the plausible biological link with increased cardiovascular risk. In 2021, the Italian Society of Arterial Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP) have joined forces and published a joint report on the relationships between AH and periodontitis, reviewing the existing scientific e...
Source: High Blood Pressure and Cardiovascular Prevention - January 6, 2023 Category: Cardiology Source Type: research

Circadian Variations in Sympathetic Vasoconstriction in Older Adults with and Without Type 2 Diabetes
ConclusionPeripheral vasoconstriction triggered by a standardized sympathetic stressor is similar between morning and evening, regardless of T2DM and different baseline VC values. However, peripheral vasoconstriction responsiveness is blunted in individuals with T2DM as handgrip-mediated sympathoexcitation induces vasodilation in the contralateral forearm in adults with T2DM and vasoconstriction in healthy age-matched controls, highlighting a neurovascular response altered by T2DM. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - January 2, 2023 Category: Cardiology Source Type: research

Early Vascular Aging in Obese Individuals with Low Cardiovascular Health
ConclusionIn this sample of obese individuals, low CVH-L8 was associated with higher peripheral and central blood pressures, and evidence of early vascular aging with arterial stiffness and endothelial dysfunction. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - December 12, 2022 Category: Cardiology Source Type: research

Elabela Peptide: A New Player in Hypertension and Vascular Damage
(Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - December 12, 2022 Category: Cardiology Source Type: research

A Novel Peptide Elabela is Associated with Hypertension-Related Subclinical Atherosclerosis
ConclusionsThis study demonstrated for the first time that circulating elabela declined in a higher stage of hypertension and hypertensive patients with increased carotid IMT, implicating that elabela may be involved in the pathogenesis of hypertension-associated subclinical atherosclerosis. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - November 30, 2022 Category: Cardiology Source Type: research

Commentary on: “HOMA-IR as a Predictor of Health Outcomes in Patients with Metabolic Risk Factors: A Systematic Review and Meta-Analysis” by González-González JG et al. High Blood Pressure & amp; Cardiovascular Prevention
(Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - November 24, 2022 Category: Cardiology Source Type: research

The Association Between Dietary Inflammatory Index (DII) and Risk of Hypertension: A Case –Control Study
ConclusionThe findings of this study suggested that adherence to a diet with a high inflammatory index could increase the risk of HTN in middle-aged men by approximately 2.9 times. However, following a diet with a high DII score had no significant relationship with HTN risk in middle-aged women. (Source: High Blood Pressure and Cardiovascular Prevention)
Source: High Blood Pressure and Cardiovascular Prevention - November 23, 2022 Category: Cardiology Source Type: research

Subclinical HMOD in Hypertension: Brain Imaging and Cognitive Function
AbstractLatest European Societies of Hypertension and Cardiology (ESH/ESC) have acknowledged that brain represent a relevant target for hypertension mediated organ damage (HMOD). In fact, brain damage can be the only HMOD in more than 30% of hypertensive subjects, evolving undetected for several years if not appropriately screened. However, no clear position has been indicated on how to evaluate brain HMOD. The present manuscript would contribute to briefly summarize structural and functional brain HMOD for the medical community dealing with older hypertensive patients. Arterial aging is proposed as possible “common soil...
Source: High Blood Pressure and Cardiovascular Prevention - November 21, 2022 Category: Cardiology Source Type: research